A recent study indicates that using an enhanced radiation protection system (Rampart M1128; Rampart IC) for performing percutaneous coronary interventions (PCI) in STEMI patients does not significantly delay treatment compared to traditional lead aprons. The study, conducted at Ascension St. Vincent Heart Center, found that the median door-to-balloon time was similar: 31.0 minutes with the Rampart system and 31.1 minutes with lead aprons, showing a nonsignificant 1.51-minute difference (P = 0.21). This suggests that the integration of enhanced radiation protection does not compromise the quality of urgent STEMI care. The study’s lead author, Dr. Osama Hallak, emphasized the importance of ensuring operator safety without affecting critical care metrics. He highlighted that while the Rampart system reduces radiation exposure and associated orthopedic strain, its use does not hinder timely patient care. The findings challenge the notion that safety measures in cath labs could slow down emergency procedures. However, the study is retrospective and conducted in a single center, leading to calls for broader research to confirm the results in varied clinical settings. Dr. Robert Riley noted the increasing market for enhanced radiation protection and the necessity for devices that protect all staff in the lab while seamlessly integrating into workflows. The study presents an optimistic outlook on improving workplace safety without compromising patient outcomes, which could enhance the appeal of the interventional cardiology specialty to new practitioners.
Fri, 09 Jan 2026 20:20:29 GMT | TCTMD.com